VIPoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
*Serum vasoactive intestinal polypeptide (VIP) levels | *Serum vasoactive intestinal polypeptide (VIP) levels | ||
*Pancreatic polypeptide levels and neurotensin levels | *Pancreatic polypeptide levels and neurotensin levels | ||
*Low serum [[potassium]], [[bicarbonate | *Low serum [[potassium]], [[bicarbonate]], and [[magnesium]] levels secondary to faecal loss | ||
*High calcium levels secondary to faecal loss | |||
*Low basal gastric acid output | *Low basal gastric acid output | ||
Revision as of 20:24, 27 October 2015
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of VIPoma laboratory findings |
|
Risk calculators and risk factors for VIPoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Laboratory tests used in the diagnosis of VIPoma include serum vasoactive intestinal polypeptide (VIP) levels, basal gastric acid output, potassium, bicarbonate, magnesium, and calcium levels.[1][2]
Laboratory Findings
- Serum vasoactive intestinal polypeptide (VIP) levels
- Pancreatic polypeptide levels and neurotensin levels
- Low serum potassium, bicarbonate, and magnesium levels secondary to faecal loss
- High calcium levels secondary to faecal loss
- Low basal gastric acid output
References
- ↑ Remme CA, de Groot GH, Schrijver G (2006). "Diagnosis and treatment of VIPoma in a female patient". Eur J Gastroenterol Hepatol. 18 (1): 93–9. PMID 16357627.
- ↑ Ghaferi AA, Chojnacki KA, Long WD, Cameron JL, Yeo CJ (2008). "Pancreatic VIPomas: subject review and one institutional experience". J Gastrointest Surg. 12 (2): 382–93. doi:10.1007/s11605-007-0177-0. PMID 17510774.